Winthrop Advisory Group LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 1 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Winthrop Advisory Group LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,998
-53.9%
10,0000.0%0.00%
-50.0%
Q2 2023$13,000
-26.1%
10,0000.0%0.00%
-33.3%
Q1 2023$17,600
-43.9%
10,0000.0%0.00%
-50.0%
Q4 2022$31,400
-35.9%
10,0000.0%0.01%
-40.0%
Q3 2022$49,000
+19.5%
10,0000.0%0.01%0.0%
Q2 2022$41,000
-29.3%
10,0000.0%0.01%
-16.7%
Q1 2022$58,000
-22.7%
10,0000.0%0.01%
-20.0%
Q4 2021$75,000
-16.7%
10,0000.0%0.02%
-25.0%
Q3 2021$90,000
-25.0%
10,000
-0.5%
0.02%
-25.9%
Q2 2021$120,000
-4.0%
10,050
+0.5%
0.03%
-12.9%
Q1 2021$125,00010,0000.03%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 2,032,980$12,950,0001.82%
EcoR1 Capital, LLC 2,308,079$14,702,0001.54%
Alexandria Capital, LLC 1,005,119$6,403,0001.05%
Casdin Capital, LLC 1,455,000$9,268,0000.98%
Rhenman & Partners Asset Management AB 700,000$4,459,0000.62%
Bellevue Group AG 3,850,000$24,525,0000.48%
GREAT POINT PARTNERS LLC 633,505$4,035,0000.42%
WASATCH ADVISORS LP 5,938,434$37,828,0000.39%
361 CAPITAL LLC 109,161$695,0000.32%
Ceeto Capital Group, LLC 50,000$319,0000.26%
View complete list of SANGAMO THERAPEUTICS INC shareholders